前列腺放疗后性少数与异性恋男性的性健康结局
这项回顾性队列研究纳入前列腺完整、放疗和雄激素剥夺治疗(ADT)后≥6个月、过去30天内有性伴侣的患者,比较性少数男性(SMM)与异性恋男性(HET)的性健康结局。接受RAI的SMM报告更差的性高潮能力、性高潮愉悦感和肛门不适;ADT与更差的性高潮能力、性高潮愉悦感、肛门疼痛和性满意度相关。
核心结论
- 前列腺癌治疗对SMM的性健康有独特影响,尤其对接受RAI者。
- 临床医生讨论治疗时应询问性取向、性别认同和性行为,以使诊疗符合个体偏好。
研究设计与样本
- 回顾性队列研究,纳入前列腺完整、放疗和ADT后≥6个月、2022年6月至2023年8月就诊、过去30天内有性伴侣的患者。
- 患者使用PROMIS性功能与满意度、SHIM和AUA问卷的部分条目自报性取向、性别认同、性行为和健康结局。
主要发现
- 总体9%接受近距离放疗,46%接受外照射放疗,45%两者均接受;14%接受ADT。
关键数值与推荐
- 接受RAI的SMM中,近距离放疗伴或不伴外照射放疗与外照射放疗 alone 相比,性高潮愉悦感更差(MD 3.1),但肛门疼痛更少(MD 5.2)。
临床怎么用
- 临床医生讨论治疗时应询问性取向、性别认同和性行为,以使诊疗符合个体偏好。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE/OBJECTIVES: To characterize the effects of prostate radiation therapy on sexual health outcomes in sexual minority men (SMM), particularly those engaging in receptive anal intercourse (RAI), and compare them with heterosexual men (HET). METHODS AND MATERIALS: This retrospective cohort study included patients with intact prostates, ≥6 months after radiation therapy and androgen deprivation therapy (ADT), seen between June 2022 and August 2023, and sexually active with a partner in the prior 30 days. Patients self-reported sexual orientation, gender identity, sexual behaviors, and health outcomes using select items from Patient-Reported Outcomes Measurement Information System Sexual Function and Satisfaction, Sexual Health Inventory for Men, and American Urological Association questionnaires. P values <.05 were considered statistically significant; mean differences (MD) ≥3 were considered clinically meaningful. RESULTS: Of eligible participants, 39% HET (n = 57/145) and 68% SMM (n = 21/31) were sexually active with a partner in the last 30 days (P = .005); including 15 (71%) SMM engaging in RAI. Overall, 9% received brachytherapy, 46% external beam radiation therapy, 45% both; 14% received ADT. The cohort reported worse orgasm ability (3.3, P < .01), orgasm pleasure (MD: 7.2, P < .001), and sexual satisfaction (MD: 3.4, P < .001) compared with US general population normative scores for sexually active adult men. SMM were more likely to be single (72% vs 33%, P < .001) and have higher prostate-specific antigen at diagnosis than HET (P = .031). SMM engaging in RAI reported worse orgasm ability (MD: 3.5), orgasm pleasure (MD: 6.3, P < .05), and anal discomfort (MD: 9.0) compared with norms. For SMM engaging in RAI, brachytherapy with/without external beam radiation therapy was associated with worse orgasm pleasure (MD: 3.1), yet less anal pain (MD: 5.2) compared with external beam radiation therapy alone; the addition of ADT was associated with worse orgasm ability (MD: 14.1, P < .05), orgasm pleasure (MD: 10.7, P < .05), anal pain (MD: 6.8), and sexual satisfaction (MD: 6.1). CONCLUSIONS: Prostate cancer treatments uniquely affect sexual health in SMM, particularly those engaging in RAI. Clinicians should inquire about sexual orientation, gender identity, and sexual behaviors when discussing treatments to align care with individual preferences.
引用
- Dickstein DR, Kapouranis T, Sigel K, et al. Sexual Health Outcomes in Sexual Minority and Heterosexual Men After Prostate Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025. PMID: 40057858. doi:10.1016/j.ijrobp.2025.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。